SOPHIRIS BIO INC.·4

Oct 29, 1:25 PM ET

SOPHIRIS BIO INC. 4

4 · SOPHIRIS BIO INC. · Filed Oct 29, 2013

Insider Transaction Report

Form 4
Period: 2013-10-25
Slover Peter T
Chief Financial Officer
Transactions
  • Award

    Common Stock (Right to Buy)

    2013-10-25+147,727147,727 total
    Exercise: $4.41From: 2014-10-25Exp: 2018-10-24Common Stock (147,727 underlying)
Footnotes (1)
  • [F1]33% of the shares subject to the option shall vest one year after the date of grant. The remainder shall vest monthly thereafter over the next two years until fully vested on October 25, 2016.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION